Bio Financial Statements From 2010 to 2025

TECH Stock  USD 73.55  0.55  0.75%   
Bio Techne financial statements provide useful quarterly and yearly information to potential Bio Techne Corp investors about the company's current and past financial position, as well as its overall management performance and changes in financial position over time. Historical trend examination of various income statement and balance sheet accounts found on Bio Techne financial statements helps investors assess Bio Techne's valuation, profitability, and current liquidity needs. Key fundamental drivers impacting Bio Techne's valuation are summarized below:
Gross Profit
773.9 M
Profit Margin
0.1286
Market Capitalization
11.5 B
Enterprise Value Revenue
9.9519
Revenue
1.2 B
We have found one hundred twenty available fundamental signals for Bio Techne Corp, which can be analyzed and compared to other ratios and to its rivals. Traders should compare all of Bio Techne Corp prevailing fundamentals against the fundamentals between 2010 and 2025 to make sure the company is sustainable this year. The Bio Techne's current Market Cap is estimated to increase to about 2.4 B. The Bio Techne's current Enterprise Value is estimated to increase to about 2.3 B

Bio Techne Total Revenue

1.4 Billion

Check Bio Techne financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Bio Techne's main balance sheet or income statement drivers, such as Depreciation And Amortization of 134.9 M, Total Revenue of 1.4 B or Gross Profit of 929.4 M, as well as many indicators such as Price To Sales Ratio of 6.9, Dividend Yield of 0.0049 or PTB Ratio of 6.78. Bio financial statements analysis is a perfect complement when working with Bio Techne Valuation or Volatility modules.
  
Check out the analysis of Bio Techne Correlation against competitors.

Bio Techne Balance Sheet

Current ValueLast YearHistorical Average 10 Year Trend
Total Assets3.3 B3.1 B1.7 B
Slightly volatile
Short and Long Term Debt Total506.6 M482.5 M283.5 M
Slightly volatile
Total Current Liabilities192.5 M183.3 M100.3 M
Slightly volatile
Total Stockholder Equity2.5 B2.4 B1.3 B
Slightly volatile
Property Plant And Equipment Net413.5 M393.8 M206.9 M
Slightly volatile
Retained Earnings1.6 B1.5 B930 M
Slightly volatile
Cash89.5 M174.6 M134.2 M
Pretty Stable
Non Current Assets Total2.5 B2.4 B1.3 B
Slightly volatile
Cash And Short Term Investments137.1 M175.8 M193.6 M
Very volatile
Net Receivables291.5 M277.6 M134.9 M
Slightly volatile
Common Stock Shares Outstanding169.2 M184.9 M155.4 M
Slightly volatile
Liabilities And Stockholders Equity3.3 B3.1 B1.7 B
Slightly volatile
Non Current Liabilities Total574.3 M547 M349.5 M
Slightly volatile
Inventory217 M206.7 M99.6 M
Slightly volatile
Other Current Assets52.4 M49.9 M18.9 M
Slightly volatile
Other Stockholder Equity990.6 M943.4 M412.8 M
Slightly volatile
Total Liabilities766.8 M730.3 M449.8 M
Slightly volatile
Total Current Assets745.5 M710 M451.3 M
Slightly volatile
Short Term Debt31.2 M29.7 M16 M
Slightly volatile
Accounts Payable45.8 M43.7 M36.1 M
Slightly volatile
Intangible Assets612.3 M583.1 M386.3 M
Slightly volatile
Property Plant And Equipment Gross723.3 M688.8 M260.9 M
Slightly volatile
Common Stock Total Equity1.9 M1.8 M700.8 K
Slightly volatile
Short Term Investments1.2 M1.2 M57.5 M
Slightly volatile
Common Stock1.9 M1.8 M702 K
Slightly volatile
Other Liabilities97.2 M114.9 M89.8 M
Slightly volatile
Property Plant Equipment139.9 M260.1 M170.9 M
Slightly volatile
Good Will1.2 B1.1 B599.8 M
Slightly volatile
Capital Surpluse871.3 M829.8 M400.8 M
Slightly volatile
Short and Long Term Debt13.7 M14.4 M31.7 M
Very volatile
Non Current Liabilities Other14.1 M11.8 M16.6 M
Very volatile
Long Term Debt Total318.6 M402.5 M248.1 M
Slightly volatile
Net Invested Capital2.3 B2.1 B1.4 B
Pretty Stable
Net Working Capital411.8 M526.7 M325.5 M
Slightly volatile
Capital Stock1.9 M1.8 M716.6 K
Slightly volatile
Capital Lease Obligations94.9 M115.6 M83.3 M
Slightly volatile

Bio Techne Income Statement

Current ValueLast YearHistorical Average 10 Year Trend
Depreciation And Amortization134.9 M128.5 M67.5 M
Slightly volatile
Total Revenue1.4 B1.3 B729.4 M
Slightly volatile
Gross Profit929.4 M885.2 M492.2 M
Slightly volatile
Other Operating Expenses1.1 B1.1 B550.2 M
Slightly volatile
Operating Income249.6 M237.7 M167.5 M
Slightly volatile
EBIT239.9 M228.5 M168.4 M
Slightly volatile
EBITDA374.8 M356.9 M235.9 M
Slightly volatile
Cost Of Revenue470.1 M447.7 M237.2 M
Slightly volatile
Total Operating Expenses679.9 M647.5 M313 M
Slightly volatile
Income Before Tax114.4 M213.5 M169.7 M
Slightly volatile
Net Income203 M193.3 M146.2 M
Slightly volatile
Income Tax Expense27.4 M20.2 M31.4 M
Pretty Stable
Research Development116.7 M111.2 M62 M
Slightly volatile
Selling General Administrative479.2 M456.3 M225.2 M
Slightly volatile
Net Income Applicable To Common Shares344.5 M328.1 M172.3 M
Slightly volatile
Net Income From Continuing Ops160.6 M193.3 M149.9 M
Slightly volatile
Interest Income1.6 MM3.5 M
Slightly volatile
Selling And Marketing Expenses40.4 M80 M42.6 M
Very volatile
Reconciled Depreciation95.3 M128.5 M79.8 M
Slightly volatile
Extraordinary Items26.6 M29.9 M32.6 M
Slightly volatile

Bio Techne Cash Flow Statement

Current ValueLast YearHistorical Average 10 Year Trend
Free Cash Flow285.1 M271.5 M173.5 M
Slightly volatile
Begin Period Cash Flow218 M207.7 M139.7 M
Slightly volatile
Depreciation134.9 M128.5 M67.5 M
Slightly volatile
Capital Expenditures75.9 M72.3 M33.2 M
Slightly volatile
Total Cash From Operating Activities361 M343.8 M206.7 M
Slightly volatile
Net Income202.9 M193.3 M145.6 M
Slightly volatile
End Period Cash Flow91.7 M174.6 M134.4 M
Pretty Stable
Stock Based Compensation45.9 M43.7 M24.3 M
Slightly volatile
Dividends Paid49.8 M58 M47.1 M
Slightly volatile

Financial Ratios

Current ValueLast YearHistorical Average 10 Year Trend
Price To Sales Ratio6.98.779.5445
Slightly volatile
Dividend Yield0.00490.00510.0085
Slightly volatile
PTB Ratio6.786.285.7647
Slightly volatile
Days Sales Outstanding45.9668.4262.5404
Pretty Stable
Book Value Per Share12.411.817.984
Slightly volatile
Free Cash Flow Yield0.0320.0240.0274
Slightly volatile
Operating Cash Flow Per Share1.791.711.2838
Slightly volatile
Average Payables3.9 M3.8 M3.4 M
Pretty Stable
Stock Based Compensation To Revenue0.01920.02950.0265
Slightly volatile
Capex To Depreciation1.20.650.6585
Pretty Stable
PB Ratio6.786.285.7647
Slightly volatile
EV To Sales6.828.989.6208
Slightly volatile
Free Cash Flow Per Share1.411.351.0813
Slightly volatile
ROIC0.07950.08370.0938
Slightly volatile
Inventory Turnover4.332.492.7199
Very volatile
Net Income Per Share1.010.960.918
Slightly volatile
Days Of Inventory On Hand85.43152140
Very volatile
Payables Turnover8.449.2311.1419
Slightly volatile
Sales General And Administrative To Revenue0.170.310.2674
Slightly volatile
Average Inventory4.4 M5.6 MM
Pretty Stable
Research And Ddevelopement To Revenue0.120.09590.094
Slightly volatile
Capex To Revenue0.0710.06240.0443
Slightly volatile
Cash Per Share0.650.871.2463
Pretty Stable
POCF Ratio23.634.033.4733
Slightly volatile
Interest Coverage14.3515.145.4657
Slightly volatile
Payout Ratio0.40.340.3617
Slightly volatile
Capex To Operating Cash Flow0.280.240.17
Pretty Stable
PFCF Ratio46.5155.0142.0151
Slightly volatile
Days Payables Outstanding40.9140.9333.7838
Slightly volatile
Income Quality1.041.61.395
Pretty Stable
ROE0.08880.09340.1211
Slightly volatile
EV To Operating Cash Flow23.3734.833.8861
Slightly volatile
PE Ratio30.9260.4648.9337
Slightly volatile
Return On Tangible Assets0.160.120.1947
Very volatile
EV To Free Cash Flow33.6244.0740.9818
Slightly volatile
Earnings Yield0.01630.01710.024
Slightly volatile
Intangibles To Total Assets0.520.490.5025
Slightly volatile
Current Ratio8.684.456.1963
Slightly volatile
Receivables Turnover7.165.525.9746
Slightly volatile
Graham Number16.7615.9612.7033
Slightly volatile
Shareholders Equity Per Share12.411.817.984
Slightly volatile
Debt To Equity0.140.180.1984
Slightly volatile
Capex Per Share0.380.360.2025
Slightly volatile
Average Receivables16.3 M18.8 M20.4 M
Slightly volatile
Revenue Per Share6.956.614.4987
Slightly volatile
Interest Debt Per Share2.612.481.8071
Slightly volatile
Debt To Assets0.0960.140.1364
Slightly volatile
Enterprise Value Over EBITDA17.2133.5227.4454
Slightly volatile
Short Term Coverage Ratios35.6226.6120.9034
Pretty Stable
Price Earnings Ratio30.9260.4648.9337
Slightly volatile
Operating Cycle131220202
Pretty Stable
Price Book Value Ratio6.786.285.7647
Slightly volatile
Days Of Payables Outstanding40.9140.9333.7838
Slightly volatile
Dividend Payout Ratio0.40.340.3617
Slightly volatile
Price To Operating Cash Flows Ratio23.634.033.4733
Slightly volatile
Price To Free Cash Flows Ratio46.5155.0142.0151
Slightly volatile
Pretax Profit Margin0.270.140.2748
Slightly volatile
Ebt Per Ebit0.860.811.1323
Very volatile
Operating Profit Margin0.260.160.2597
Slightly volatile
Effective Tax Rate0.10.110.1954
Slightly volatile
Company Equity Multiplier1.391.51.39
Very volatile
Long Term Debt To Capitalization0.10.120.1339
Slightly volatile
Total Debt To Capitalization0.110.150.1563
Slightly volatile
Return On Capital Employed0.08870.09340.122
Slightly volatile
Debt Equity Ratio0.140.180.1984
Slightly volatile
Ebit Per Revenue0.260.160.2597
Slightly volatile
Quick Ratio3.03.164.8733
Slightly volatile
Dividend Paid And Capex Coverage Ratio4.843.032.735
Slightly volatile
Net Income Per E B T0.580.810.7817
Slightly volatile
Cash Ratio0.810.862.1519
Slightly volatile
Cash Conversion Cycle103188172
Very volatile
Operating Cash Flow Sales Ratio0.240.230.2829
Pretty Stable
Days Of Inventory Outstanding85.43152140
Very volatile
Days Of Sales Outstanding45.9668.4262.5404
Pretty Stable
Free Cash Flow Operating Cash Flow Ratio0.60.710.8194
Slightly volatile
Cash Flow Coverage Ratios0.780.822.6669
Slightly volatile
Price To Book Ratio6.786.285.7647
Slightly volatile
Fixed Asset Turnover5.423.894.6193
Slightly volatile
Capital Expenditure Coverage Ratio6.844.287.5718
Slightly volatile
Price Cash Flow Ratio23.634.033.4733
Slightly volatile
Enterprise Value Multiple17.2133.5227.4454
Slightly volatile
Debt Ratio0.0960.140.1364
Slightly volatile
Cash Flow To Debt Ratio0.780.822.6669
Slightly volatile
Price Sales Ratio6.98.779.5445
Slightly volatile
Return On Assets0.06790.07150.092
Slightly volatile
Asset Turnover0.850.490.548
Slightly volatile
Net Profit Margin0.190.130.2125
Pretty Stable
Gross Profit Margin0.560.60.6614
Pretty Stable
Price Fair Value6.786.285.7647
Slightly volatile
Return On Equity0.08880.09340.1211
Slightly volatile

Bio Techne Valuation Data

Current ValueLast YearHistorical Average 10 Year Trend
Market Cap2.4 B2.3 B2.4 B
Slightly volatile
Enterprise Value2.3 B2.2 B2.2 B
Slightly volatile

Bio Fundamental Market Drivers

Forward Price Earnings38.1679
Cash And Short Term Investments152.9 M

Bio Upcoming Events

1st of February 2024
Upcoming Quarterly Report
View
1st of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
13th of August 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
30th of June 2023
Last Financial Announcement
View

About Bio Techne Financial Statements

Investors use fundamental indicators, such as Bio Techne's revenue or net income, to determine how well the company is positioned to perform in the future. Although Bio Techne's investors may analyze each financial statement separately, they are all interrelated. Understanding these patterns can help investors make the right trading decisions.
Last ReportedProjected for Next Year
Current Deferred Revenue32.1 M33.7 M
Total Revenue1.3 B1.4 B
Cost Of Revenue447.7 M470.1 M
Stock Based Compensation To Revenue 0.03  0.02 
Sales General And Administrative To Revenue 0.31  0.17 
Research And Ddevelopement To Revenue 0.10  0.12 
Capex To Revenue 0.06  0.07 
Revenue Per Share 6.61  6.95 
Ebit Per Revenue 0.16  0.26 

Currently Active Assets on Macroaxis

When determining whether Bio Techne Corp offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Bio Techne's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Bio Techne Corp Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Bio Techne Corp Stock:
Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bio Techne. If investors know Bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bio Techne listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.32)
Dividend Share
0.32
Earnings Share
0.96
Revenue Per Share
7.424
Quarterly Revenue Growth
0.045
The market value of Bio Techne Corp is measured differently than its book value, which is the value of Bio that is recorded on the company's balance sheet. Investors also form their own opinion of Bio Techne's value that differs from its market value or its book value, called intrinsic value, which is Bio Techne's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bio Techne's market value can be influenced by many factors that don't directly affect Bio Techne's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bio Techne's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bio Techne is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bio Techne's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.